Sleep Apnea Diagnostic Systems Market Report 2025

This Sleep Apnea Diagnostic Systems market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The sleep apnea diagnostic systems market size has grown strongly in recent years. It will grow from $6.28 billion in 2024 to $6.8 billion in 2025 at a compound annual growth rate (CAGR) of 8.23%. The growth in the historic period can be attributed to several factors, including increasing awareness of sleep disorders, a rise in the prevalence of obesity and aging populations, the growing adoption of home sleep testing devices, supportive healthcare policies, and expanding healthcare infrastructure in emerging economies.

The sleep apnea diagnostic systems market size is expected to see strong growth in the next few years. It will grow to $9.23 billion in 2029 at a compound annual growth rate (CAGR) of 7.97%. Looking to the forecast period, growth is expected to be driven by the increasing adoption of home sleep testing devices, greater awareness about sleep disorders and their health impacts, supportive government and insurance policies, a rising prevalence of obesity and aging populations, and the expansion of telemedicine services. Major trends anticipated in the forecast period include the development of portable diagnostic devices, the integration of cloud-based data management for better monitoring and analysis, advancements in polysomnography technology, integration with smart home ecosystems for improved patient care, innovations in home sleep testing devices, and the use of AI for enhanced data analysis and diagnosis, all aimed at improving accessibility and accuracy in diagnosing sleep disorders.

The growing prevalence of sedentary lifestyles is anticipated to boost the sleep apnea diagnostic systems market in the future. A sedentary lifestyle is characterized by little physical activity and extended periods of sitting or lying down. This lifestyle is becoming more common due to factors such as greater dependence on technology, urbanization, a preference for convenience, and longer working hours. Sleep apnea diagnostic systems play a crucial role in addressing the health risks tied to sedentary behavior by identifying and monitoring sleep disorders early. This allows for timely interventions that can enhance sleep quality and reduce related issues such as obesity, heart disease, and fatigue. For example, in June 2024, the Australian Institute of Health and Welfare reported that, according to the ABS National Health Survey in 2022, 83% of young people aged 15-17 and nearly 40% of adults aged 18-64 were not active enough to meet recommended physical activity levels. Similarly, the Office for National Statistics in the UK revealed that between April 2021 and March 2022, a significant portion of older adults were classified as inactive, with inactivity rates reaching 89.3% for those aged 65 and older. These trends indicate that the rise in sedentary lifestyles is a key factor driving the sleep apnea diagnostic systems market.

Leading companies in the sleep apnea diagnostic systems market are prioritizing the development of innovative technologies, such as pneumatic sensors, to improve the precision, effectiveness, and comfort of sleep apnea detection and monitoring. This focus aims to enhance patient outcomes and broaden market reach. Pneumatic sensors detect changes in airflow and pressure within the respiratory system, helping identify irregular breathing patterns and assisting in the diagnosis of sleep apnea. For example, in September 2024, Withings Inc., a French consumer electronics company, received approval from the U.S. Food and Drug Administration for its Sleep Rx Mat. This contactless device monitors sleep patterns, detects apnea events, and offers actionable insights to enhance sleep health. The device features a pneumatic sensor to track respiratory rate, body movement, and continuous heart rate. Designed as a discreet mat, it requires a single setup and fits easily under any mattress, eliminating the need for masks or bulky equipment. Once in place, it provides detailed analyses of sleep patterns, breathing, and cardiovascular activity throughout the night.

In May 2023, DynaFlex, a U.S.-based company specializing in orthodontic supplies and manufacturing, acquired WholeYou/Respire Medical to broaden its obstructive sleep apnea (OSA) product portfolio. This acquisition strengthens DynaFlex’s market position and ensures it can continue to provide high-quality services to meet current and future customer needs. WholeYou/Respire Medical is a U.S.-based manufacturer that specializes in creating solutions for OSA.

Major players in the sleep apnea diagnostic systems market are Koninklijke Philips N.V., GE Healthcare Technologies Inc., ResMed Inc., Teleflex Incorporated, Nihon Kohden Corporation, Fisher And Paykel Healthcare, DeVilbiss Healthcare LLC, Natus Medical Incorporated, Itamar Medical Ltd., BMC Medical Co. Ltd., Compumedics Ltd., Advanced Brain Monitoring Inc., Cleveland Medical Devices Inc., NeuroVirtual, FusionSleep, Lowenstein Medical, Braebon Medical Corporation, Acurable, SOMNOmedics GmbH, Nox Medical.

North America was the largest region in the sleep apnea diagnostic systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sleep apnea diagnostic systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the sleep apnea diagnostic systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Sleep apnea diagnostic systems refer to medical technologies and devices used to detect, monitor, and evaluate sleep-related breathing disorders, specifically sleep apnea. These systems assess various physiological parameters such as airflow, oxygen saturation, heart rate, and brain activity during sleep to identify disruptions, enabling accurate diagnosis and effective management of the condition.

The primary products in the sleep apnea diagnostic systems market include polysomnography devices, nasal flow sensors, peripheral capillary oxygen saturation (SpO2) sensors, and actigraphy monitoring devices. Polysomnography devices are comprehensive systems used to monitor and record physiological parameters, providing detailed data on sleep stages and disturbances, which are critical for diagnosing sleep disorders such as sleep apnea. The technologies involved in these systems include non-invasive technology, invasive technology, wearable technology, and diagnostic software. Key end users include home care settings, hospitals, sleep centers, and clinics.

The sleep apnea diagnostic systems market research report is one of a series of new reports that provides sleep apnea diagnostic systems market statistics, including the sleep apnea diagnostic systems industry global market size, regional shares, competitors with the sleep apnea diagnostic systems market share, detailed sleep apnea diagnostic systems market segments, market trends, and opportunities, and any further data you may need to thrive in the sleep apnea diagnostic systems industry. This sleep apnea diagnostic systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sleep apnea diagnostic systems market consists of revenues earned by entities by providing services such as in-laboratory polysomnography (PSG) testing, home sleep testing (HST), and telemedicine and remote consultation. The market value includes the value of related goods sold by the service provider or included within the service offering. The sleep apnea diagnostic systems market includes sales of snore sensors, pulse oximeters, airflow monitors, home sleep testing (HST) devices, and electroencephalogram (EEG) sensors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.